At a time when many countries are doing everything they can to gain access to vaccines, there are some who think about what to do with the batches of vaccines that are no longer used, after the concerns about the risks.
Several countries have reduced AstraZeneca and Johnson & Johnson vaccines for younger ages, leaving stocks unavailable.
Denmark has completely stopped its vaccine AstraZeneca, sparking an international interest in the 2.4 million doses it has ordered. The Czech Republic offered to buy “all AstraZeneca vaccines from Denmark”, at the same time as Estonia, Latvia and Lithuania showed interest.
Something similar happens with the Johnson & Johnson vaccine, America temporarily froze its administration, having ordered 100 million doses, as did South Africa recently.
South Africa has sold 1 million doses of the AstraZeneca vaccine in 14 African countries.
What can countries do that do not want the vaccines of the two companies associated with rare thrombosis?
Theoretically, they can sell them or give them away wherever they want. This is what the European director of the World Health Organization, Hans Kluge, hinted at what Denmark is trying to do.
Countries have shown interest, but Denmark is keeping its papers closed for the time being.
There is also an international plan for the equitable distribution of unvaccinated vaccines. It is called Covax, it is handled by the WHO and it wants them to be divided equally between rich and poor nations.
By the end of 2021, Covax estimates that it will have delivered over 2 billion doses of its vaccines coronavirus in 190 countries.
How this will be done, no one knows for now…
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
